Cyclobutanes in small‐molecule drug candidates
MR van der Kolk, MACH Janssen, FPJT Rutjes… - …, 2022 - Wiley Online Library
Cyclobutanes are increasingly used in medicinal chemistry in the search for relevant
biological properties. Important characteristics of the cyclobutane ring include its unique …
biological properties. Important characteristics of the cyclobutane ring include its unique …
Drug resistant Tuberculosis: A review
JL Khawbung, D Nath, S Chakraborty - … immunology, microbiology and …, 2021 - Elsevier
Tuberculosis (TB) was announced as a global emergency in 1993. There was an alarming
counter attack of TB worldwide. However, when it was known that TB can be cured …
counter attack of TB worldwide. However, when it was known that TB can be cured …
Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles' heel for the TB-causing pathogen
A Maitra, T Munshi, J Healy, LT Martin… - FEMS microbiology …, 2019 - academic.oup.com
Tuberculosis (TB), caused by the intracellular pathogen Mycobacterium tuberculosis,
remains one of the leading causes of mortality across the world. There is an urgent …
remains one of the leading causes of mortality across the world. There is an urgent …
Drug Resistance Mechanisms in Mycobacterium tuberculosis
JC Palomino, A Martin - Antibiotics, 2014 - mdpi.com
Tuberculosis (TB) is a serious public health problem worldwide. Its situation is worsened by
the presence of multidrug resistant (MDR) strains of Mycobacterium tuberculosis, the …
the presence of multidrug resistant (MDR) strains of Mycobacterium tuberculosis, the …
Mechanisms of pyrazinamide action and resistance
Pyrazinamide (PZA) is a unique antituberculosis (anti-TB) drug that plays a key role in
shortening TB therapy. PZA kills nonreplicating persisters that other TB drugs fail to kill …
shortening TB therapy. PZA kills nonreplicating persisters that other TB drugs fail to kill …
Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs
PE Almeida Da Silva… - Journal of antimicrobial …, 2011 - academic.oup.com
Tuberculosis (TB) remains one of the leading public health problems worldwide. Declared
as a global emergency in 1993 by the WHO, its control is hampered by the emergence of …
as a global emergency in 1993 by the WHO, its control is hampered by the emergence of …
Nanotechnology: intelligent design to treat complex disease
P Couvreur, C Vauthier - Pharmaceutical research, 2006 - Springer
The purpose of this expert review is to discuss the impact of nanotechnology in the treatment
of the major health threats including cancer, infections, metabolic diseases, autoimmune …
of the major health threats including cancer, infections, metabolic diseases, autoimmune …
Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies
M Fauvart, VN De Groote… - Journal of medical …, 2011 - microbiologyresearch.org
Certain infectious diseases caused by pathogenic bacteria are typically chronic in nature.
Potentially deadly examples include tuberculosis, caused by Mycobacterium tuberculosis …
Potentially deadly examples include tuberculosis, caused by Mycobacterium tuberculosis …
Mechanisms of Drug Resistance in Mycobacterium tuberculosis
Y Zhang, C Vilchèze… - Tuberculosis and the …, 2004 - Wiley Online Library
Drug resistance in tuberculosis (TB) is a particular problem because the lengthy therapy of
at least 6 months makes patient compliance very difficult, which frequently creates drug …
at least 6 months makes patient compliance very difficult, which frequently creates drug …
A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages
R Van der Geize, K Yam, T Heuser… - Proceedings of the …, 2007 - National Acad Sciences
Rhodococcus sp. strain RHA1, a soil bacterium related to Mycobacterium tuberculosis,
degrades an exceptionally broad range of organic compounds. Transcriptomic analysis of …
degrades an exceptionally broad range of organic compounds. Transcriptomic analysis of …